Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
The board of directors hereby convenes for an extraordinary general meeting in Orphazyme A/S at the company’s address at Lyskjær 8A, 2730 Herlev on Thursday 30 November 2023 at 10.00 AM (CET). ...
-
Unless otherwise stated, comments in this announcement refer to performance from continuing operations from 1 January – 31 October 2023. Net loss for the 10 months ended October 2023 totaled DKK 29...
-
At the company’s extraordinary general assembly November 2nd 2023 it was decided to implement a reverse share split at a consolidation ratio of 1.000:1, see company announcement 18/2023. The reverse...
-
The company convened its extraordinary general assembly today November 2nd 2023 10.00 AM (CEST) at its office address, Lyskær 8A, 2730 Herlev, see company announcement 17/2023 for the full...
-
The Board of Directors hereby convenes an Extraordinary General Meeting to be held at the Company’s address at Lyskjær 8A, 2730 Herlev on Thursday November 2nd 2023 at 10:00 AM (CEST). Agenda: ...
-
As described in Company Announcements 12/2023, the strategy for Orphazyme is to optimize the cost structure of the company, while the search for a new activity is ongoing. To reduce the running...
-
In accordance with the authorization from the General Meeting on May 17’th 2023 and Company announcement 8/2023 the Board of Directors in Orphazyme A/S has today introduced an incentive program for...
-
As communicated several times, latest in Company announcement 12/2023, Orphazyme is part of a US class action lawsuit. The court has granted preliminary approval of the proposed settlement and...
-
As mentioned in announcement 11/2023 the Company and CEO/CFO Anders Fink Vadsholt entered into a severance agreement at May 30th 2023, where Mr. Vadsholt would step down as CEO/CFO of the Company no...
-
Business updates and Financial highlights First Half 2023:Unless otherwise stated, comments in this announcement refer to H1 performance from continuing operations. In 2022, the business operations...